Ligand Pharmaceuticals (LGND)
(Delayed Data from NSDQ)
$166.51 USD
-3.32 (-1.95%)
Updated Sep 19, 2025 04:00 PM ET
After-Market: $166.38 -0.13 (-0.08%) 7:58 PM ET
NA Value
NA Growth NA Momentum NA VGMFundamental Charts
About Market Cap
As of the previous market close, Ligand Pharmaceuticals Incorporated has a market cap of $3.33B, which represents its share price of $169.83 multiplied by its outstanding shares number of 19.60M. As a mid-cap company, LGND's shareholders are generally exposed to less risk than shareholders of small-cap companies but more risk than large-cap companies.
The company's Market Capitalization is a measurement of company size. It is calculation of the company's share price times the number of outstanding shares. Large market cap companies give stability and are good long-term investments. Small market cap companies can produce faster growth and bigger returns, but their stockholders are exposed to more risk.
LGND 166.51 -3.32(-1.95%)
Will LGND be a Portfolio Killer in September?
Zacks Investment Research is releasing its prediction for LGND based on the 1-3 month trading system that more than doubles the S&P 500.
Other News for LGND
Is LGND gathering momentum? Bollinger Band Squeeze shows up after dropping 1.95%
LGND makes New 52 Week Closing High on September 18
LGND falls 0.5% on September 18, leaving the technical picture intact
Pocket Pivot appears for LGND after 0.44% move
LGND forms 20 Day Moving Average Support on September 15